Clinical Trial Update: A Study of Herceptin (Trastuzumab) in Combination With 2nd-Line Chemotherapy in Patients With HER2 Positive Metastatic Breast Cancer. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Herceptin (trastuzumab) in combination with second-line chemotherapy in HER2-positive metastatic breast cancer has completed, with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-06-21